LD-2 disclosure · 1st Quarter - Report
HOSPIRA, INC.
Client
- Name
- HOSPIRA, INC.
- Description
- Device and drug manufacturer
- Location
- Illinois · United States of America
Registrant
- Description
- Law Firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
2 issuesHealth Issues
Implementation of the Biologics Price Competition and Innovation Act (BPCIA)
LobbyistsHENRY W MENN iii · LISA LAYMAN · ROBERT DENNIS FOREMAN
Covered position (HENRY W MENN iii): CoS, Sen. Bob Graham (2001 - 2004); Min SD & Counsel, Cmte on Vet Affairs (2004); Sp Asst Leg Aff, FDA Office of Commissioner (1993-1995)
Covered position (LISA LAYMAN): SPA, Sen Stabenow (2005-2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)
Covered position (ROBERT DENNIS FOREMAN): The Office of U.S. Senator Orrin Hatch, Senior Health Policy Advisor, (1993 - 2001); Centers for Medicare & Medicaid Services (CMS), Director, Office of Legislation and Congressional Affairs, (2001 - 2005)
TargetedSENATE · HOUSE OF REPRESENTATIVES
Pharmacy
Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products Proposed Rule by FDA (RIN:0910-AG94)
LobbyistsHENRY W MENN iii · LISA LAYMAN · ROBERT DENNIS FOREMAN
Covered position (HENRY W MENN iii): CoS, Sen. Bob Graham (2001 - 2004); Min SD & Counsel, Cmte on Vet Affairs (2004); Sp Asst Leg Aff, FDA Office of Commissioner (1993-1995)
Covered position (LISA LAYMAN): SPA, Sen Stabenow (2005 - 2007); SPA, Sen Graham (2001 - 2004); LA, Sen Bryan (2000); LA, Sen Chafee (1997 - 1999); CBO, PA (1992 - 1996)